BALL MEMORIAL HOSPITAL
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $1.1M
- Transactions
- 295
- Companies
- 28
- Average per transaction
- $3,671
Who reported the payments
| Novartis | $200,533 |
| AstraZeneca | $193,853 |
| Astrazeneca UK Limited | $85,694 |
| Livanova USA, Inc. | $84,329 |
| Amgen | $72,362 |
| Lilly USA, LLC | $62,000 |
| Endovascular Engineering Inc. | $56,496 |
| Stryker | $53,772 |
| CSL Behring | $45,049 |
| Genentech, Inc. | $42,978 |
| Boston Scientific | $40,126 |
| Roche Products Limited | $30,103 |
| Sanofi US Services Inc. | $23,504 |
| Travere Therapeutics, Inc. | $20,098 |
| Sumitomo Pharma America, Inc. | $20,000 |
| Merck | $11,642 |
| Eli Lilly | $9,305 |
| Roche Diagnostics Corporation | $8,848 |
| Janssen Research & Development, LLC | $6,446 |
| Medical Device Business Services, Inc. | $6,200 |
| ZOLL Circulation Inc | $4,010 |
| F. Hoffmann-la Roche AG | $3,008 |
| Central Admixture Pharmacy Services, Inc. | $765 |
| Lexicon Pharmaceuticals, Inc. | $750 |
| Fujifilm Sonosite, Inc. | $680 |
| Johnson & Johnson | $333 |
| Convatec Inc. | $156 |
| GE HealthCare | $35 |